Lanxess as one of Currenta's main customers will provide MIRA with operational support during the transition phase and will therefore continue to hold its stake in Currenta for several months longer. You can sign up to receive it directly here. In addition, Lanxess is entitled to a profit participation until completion of the transaction. Currenta manages and operates infrastructure, energy supply and other essential services across the chemical parks in Leverkusen, Dormagen and Krefeld-Uerdingen and is currently a joint venture of Bayer (60 percent) and Lanxess (40 percent). Specialty chemicals company LANXESS April 30, 2020 completed the sale of its 40 percent stake in chemical park operator Currenta to Macquarie Infrastructure and Real Assets (MIRA). When all of the discarded materials you receive are recycled or used to generate renewable energy, what do you do with the landfill where garbage was buried for decades? For a climate-friendly industry: Using carbon dioxide and hydrogen as raw ma ... Pyrolysis oil from waste tires as additional raw material source, LyondellBasell Successfully Starts Up New Pilot Molecular Recycling Facility, analytica 2020: World’s leading trade fair to be held virtually, Merck: Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021, New storage battery more efficient and heat-resistant, Soft matter on new ways to self-organization. The vessel MIRA (IMO: 9116668, MMSI 636017302) is a Bulk Carrier built in 1996 (24 years old) and currently sailing under the flag of Liberia. MIRA believes Currenta’s experienced workforce are critical to the businesses’ success.

What we call waste is merely someone’s unwanted materials. Active in Germany for 30 years, MIRA has extensive experience in Currenta’s core business areas including utilities, transport, logistics, storage, waste management and treatment services. About CURRENTA.

The sale is part of Bayer's plan to divest from non-strategic ventures, after its purchase of US firm Monsanto. Bayer had already completed the sale of its Currenta stake to MIRA at the end of November 2019. Bayer and Lanxess announced that they will sell their stakes in the chemical park operator Currenta to funds managed by the infrastructure investor Macquarie Infrastructure and Real Assets (MIRA). A California judge cut a $2 billion jury verdict against Bayer-owned Monsanto over its Roundup weed killer to $86.7 million. Currenta's future owner MIRA told Reuters that the company was committed to keeping Currenta in its current structure and would not sell parts over the next three years. To ensure Connecticut maintains its place as a leader in recycling, solid waste, and sustainable  materials management, MIRA is also partnering with the Connecticut Department of Energy & Environmental Protection (“DEEP”) and embarking on a redevelopment of these facilities and systems to take advantage of cutting-edge technology. Moreover, Lanxess has reached an agreement with MIRA on service and supply contracts for the three sites in Leverkusen, Dormagen and Krefeld, which will initially run for ten years. The move comes as Bayer has faced enormous pressure from a wave of cancer lawsuits against its recently acquired subsidiary Monsanto, relating to its flagship Roundup weed killer, which contains the herbicide glyphosate. <> CURRENTA offers services for the chemical industry. The German company is still facing lawsuits from more than 13,400 plaintiffs over glyphosate-based weed-killer Roundup. In MIRA's case we used a closed landfill to build Connecticut's first landfill-based solar generating facility. Bayer had already completed the sale of its Currenta stake to MIRA at the end of November 2019. These recyclables are sorted and processed into market-ready commodities which can be used to manufacture new products. The vessel is en route to the port of Kuantan, sailing at a speed of 9.1 knots and expected to arrive there on Aug 12, 03:00..

As one of Currenta's main customers, Lanxess will provide MIRA with operational support during the transition phase and will continue to hold its stake in Currenta for several months longer than Bayer, which expects its part of the transaction to close in the fourth quarter of 2019.